P PRIMESTOCKFINDER.COM

ILA Shares Island Pharmaceuticals Limited

ASX · ASX
$0.31 +0.00% Prices as of close 2026-10-27

Last in our picks 2026-10-15 — not in the current list; analysis below is from that screen

Antiviral development platform offers catalyst-driven upside and comparatively stronger projected growth.

Future value: $0.58 (+70.59%) · 6-12 months

Signal breakdown

  • ▸Strong projected growth and clinical development catalysts.
  • ▾Below 50-day MA (-20.04%)
  • ▸Volume 3.28× average — accumulation
  • ▾Near 52-week low (9.4% of range)
  • ▸~71% upside to price target

Is ILA a buy right now?

Trend: ILA is trading below the 50-day average (-22.50%), RSI 39 — neutral momentum, with a 3-month return of -19.48%.

Valuation & quality: Island Pharmaceuticals Limited trades on forward P/E 0.2, price-to-book 6.89; fundamentals show net margin 0.0%, return on equity -95.5%, revenue growth 996.0% year on year.

Analyst consensus: 1 analysts have a mean 12-month price target of A$1.60 (+416.1% vs the last close; range A$1.60 – A$1.60), consensus rating “strong buy”.

Our screen: BUY (score 3) — Antiviral development platform offers catalyst-driven upside and comparatively stronger projected growth.

Computed from end-of-day data; not personal advice.

12-month price chart

0.49 0.31 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.31 – 0.49.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+8.10%-5.00%+0.00%+0.00%+2.60%+12.80%-15.90%-16.20%

Fundamentals

Market cap
$91.7M
P/E (ttm)
0.3
Forward P/E
0.2
EPS (ttm)
$-0.04
Price / book
6.89
Beta
0.17
Net margin
0.0%
ROE
-95.5%
Revenue growth
996.0%
Revenue (ttm)
$282,657
Free cash flow
$-2,088,113
52-wk range
$0.30 – $0.63
Volume
38,586
Avg volume (3m)
202,212

Analyst price target

Mean target
$1.60
Low
$1.60
High
$1.60
Analysts
1
Consensus
STRONG BUY

Technical signals

RSI (14)
38.7
vs 50-day MA
-22.50%
1-mo return
-20.51%
3-mo return
-19.48%
Volume z-score
-0.36

About Island Pharmaceuticals Limited

Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States.

Sector: Healthcare · Industry: Biotechnology · Australia · Website

Related Biotech picks

CSL.AXCSL LimitedMSB.AXMesoblast LimitedIMR.AXImricor Medical SystemSLD.AXSaluda Medical, Inc.NUZ.AXNeurizon Therapeutics NEU.AXNeuren PharmaceuticalsDXB.AXDimerix LimitedNYR.AXNyrada Inc.

Browse: all ASX stocks · Biotech picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.